ABVD versus BEACOPP for Hodgkin's Lymphoma When High-Dose Salvage Is Planned

Treatment with BEACOPP, as compared with ABVD, resulted in better initial tumor control, but the long-term clinical outcome did not differ significantly between the two regimens. (Funded by Fondazione Michelangelo; ClinicalTrials.gov number, NCT01251107.).